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Abstract
Background: Surgeons may improve their decision making by assessing the extent to which their
initial clinical diagnosis of a surgical site infection (SSI) was supported by culture results. Aim of the
present study was to evaluate routinely reported SSI by surgeons against microbiological culture
results, to identify patient groups with lower agreement where decision making may be improved.
Methods: 701 admissions with SSI were reported by surgeons in a university medical centre in the
period 1997-2005, which were retrospectively checked for microbiological culture results.
Reporting a SSI was conditional on treatment being given (e.g. antibiotics) and was classified by
severity. To identify specific patient groups, patients were classified according to the surgery group
of the first operation during admission (e.g. trauma).
Results: Of all reported SSI, 523 (74.6%) had a positive culture result, 102 (14.6%) a negative
culture result and 76 (10.8%) were classified as unknown culture result (due to no culture taken).
Given a known culture result, reported SSI with positive culture results less often concerned
trauma patients (16% versus 26%, X2 = 4.99 p = 0.03) and less severe SSI (49% versus 85%, X2 =
10.11 p < 0.01) suggesting that a more conservative approach may be warranted in these patients.
The trauma surgeons themselves perceived to have become too liberal in administering antibiotics
(and reporting SSI).
Conclusion: Routine reporting of SSI was mostly supported by culture results. However, this
support was less often found in trauma patients and less severe SSI, thereby giving surgeons
feedback that diagnosis and treatment may be improved in these cases.
Background
Between 2%-5% of all patients undergoing extraabdomi-
nal operations and up to 20% of all patients undergoing
intraabdominal operations will develop a surgical site
infection (SSI) [1]. Patients who develop SSI have longer
hospitalizations, are twice as likely to die, 60% more
likely to spend time in an ICU, and more than five times
more likely to be readmitted to the hospital. Reduction of
the incidence of SSI can substantially decrease morbidity
and mortality and reduce the economic burden for
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patients and hospitals [2,3]. For these reasons, both med-
ical professionals and policy makers in hospitals are inter-
ested in monitoring SSI.
Several definitions exist to define a SSI, such as the Noso-
comial Infection National Surveillance Service (NINSS),
the presence of pus, and the ASEPSIS scoring method
[4,5]. But the most commonly used definition is that as
defined by the Centers for Disease Control and preven-
tion (CDC) National Nosocomial Infection Survey
(NNIS) [6]. The CDC NNIS definition includes a SSI if
one out of four criteria is fulfilled: (1) purulent drainage
(2) a positive culture result from wound swab (3) local
symptoms and opened by a surgeon, unless culture result
is negative (4) when the diagnosis is made by a surgeon or
physician. The CDC NNIS definition is advocated to be
adopted as the universal, single, definition of SSI [7], as it
is known that even small differences in definition may
result in large differences in outcome, making compari-
sons between definitions unreliable [6].
Problems may occur in everyday clinical practice when
attending physicians cannot afford to wait for culture
results to materialize before starting subsequent treat-
ment. This is addressed by the CDC NNIS definition, as
merely the diagnosis of the attending physician is suffi-
cient to include it. Key to helping surgeons to improve
their decision making is to learn from SSI reporting data
in the past, and the extent to which their diagnosis was
supported by culture results. Since 1997 the department
of surgery of the Leiden University Medical Centre
(LUMC) is reporting SSI, as part of their reporting system
of adverse outcomes for all surgical admissions. Prelimi-
nary results of these data have shown an increase in
reported SSI from 2002 onwards [8] and the question is
whether these reported SSI are supported by culture
results.
Aim of the present study was to evaluate routinely
reported SSI by surgeons against microbiological culture
results, to identify patient groups with lower agreement
where decision making may be improved.
Methods
Patients and definitions
All 701 surgical admissions in which a SSI was diagnosed
in the LUMC in the period 1997-2005 were included. All
adverse outcomes, including all SSI are prospectively
recorded throughout admission on separate forms by sur-
geons and residents as part of routine medical care [9].
These forms are discussed on a weekly basis by a team of
surgeons and residents for validity and possible preventa-
bility of adverse outcomes. Adverse outcomes are reported
if they are so harmful to the patient's health that treatment
is needed and/or the outcome results in permanent dam-
age [10]. A previous study has shown that such a routine
reporting system is an effective method to identify adverse
outcomes [11]. As a result, a SSI will be reported if diag-
nosed and treated by a surgeon (in addition to prophylac-
tic antibiotic treatment being given according to
protocol), without knowledge of culture results at the
time of reporting since these are not available at that
point.
SSI - as all adverse outcomes - are classified in one of the
following categories of severity: (1) temporary health dis-
advantage, recovery without (re) operation; (2) recovery
after (re) operation; (3) (probably) permanent damage or
function loss; and (4) death [10]. In the present study, less
severe SSI were defined as SSI with severity category 1,
while severe SSI included all other severity categories.
Although SSI are commonly differentiated between inci-
sional and organ/space infections, this is not yet incorpo-
rated into the adverse outcome reporting so that these
data are unavailable. Furthermore, surgical wound class
[12] is not registered routinely by surgeons in our hospital
or elsewhere in the Netherlands. Since findings during
surgery determine the wound class which are not (com-
pletely) reported in patients medical records, it is not pos-
sible to collect these data retrospectively in a reliable way.
These data are therefore unavailable for the present study.
To assess whether results differed for specific groups of
surgical patients, under the care of different wards and
groups of surgeons, procedures performed in surgical
patients were classified into surgery groups, according to
the list of Operations 1999, which is developed and used
by the Association of Surgeons in the Netherlands
[13,14]. Patients were classified according to the surgery
group of the first operation during admission, indicating
the type of operation (and therefore type of patient). Four
main groups were thus distinguished: (cardio)vascular
surgical patients, trauma patients, patients undergoing
surgery in digestive or gastrointestinal tract, and all other
surgical patients. Patients with different surgery groups
within the first operation were classified in the group all
other surgical patients. All subsequent surgery during
(re)admission is also included, to enable classification of
severity of SSI (and other adverse outcomes).
Culture results
All admissions with a reported SSI were retrospectively
checked for culture results recorded electronically in the
Hospital Information System. SSI with positive culture
results from either wound or blood, within thirty days
after the operation date were included. The thirty day win-
dow was chosen according to the NNIS-criteria [6]. Posi-
tive cultures from unrelated locations, e.g. lung or urine
were ignored and did not contribute to the data presented.
Cultures showing no growth were recorded as negative.BMC Infectious Diseases 2009, 9:176 http://www.biomedcentral.com/1471-2334/9/176
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SSI in patients with no cultures taken within that time
frame were recorded as unknown. For these patients we
checked the medical records for clinical symptoms/crite-
ria of a SSI and/or subsequent treatment, as well as any
other information possibly explaining the lack of a cul-
ture.
Survey
To identify the surgeon's views on the diagnosis and treat-
ment of SSI, a survey was conducted among all surgical
staff. The survey was carried out by telephone by a single
person (MK) using a structured format and a duration of
approximately 10 minutes. All 23 surgeons on permanent
staff responded.
The survey consisted of open-ended questions on diagno-
sis, treatment and risk factors of SSI. We first identified the
criteria for diagnosis and subsequent treatment of a SSI as
used by each surgeon. Each surgeon could mention mul-
tiple criteria, which were retrospectively classified into
groups. Secondly, we asked whether the surgeons per-
ceived antibiotic treatment policy to be liberal or not.
Finally, we asked whether risk factors existed in which
case they would give antibiotic treatment sooner than
when the above criteria were met, and what these risk fac-
tors were. Each surgeon could mention multiple risk fac-
tors, which were retrospectively classified into groups.
The Medical Ethical Committee of the Leiden University
Medical Centre declared that formal ethical approval and
written informed consent was not needed for this study
under Dutch law.
Statistical analysis
SSI with known and unknown culture results were first
compared on other (patient) characteristics to assess
whether no cultures were obtained in a particular group of
patients, type of SSI or time period which may bias our
results. Chi-square tests were used for categorical variables
and t-tests for continuous variables. Characteristics
included were: age at admission, sex, time period, ASA
[15] class of first operation during admission as a measure
of the patient's health status at admission, severity of SSI
and type of surgical patients as defined by surgery group.
ASA class was categorised with ASA class 3-5 taken as a
measure of high-risk patients [16]. Time period was cate-
gorised into recent years (2003-2005) and earlier years
(1997-2002) based on the increase in reported SSI [8].
Type of patients were grouped into trauma patients, (car-
dio)vascular patients, patients having surgery on digestive
or gastrointestinal tract, and all other patients.
Within the group with known culture results, we then
compared SSI with positive and negative culture results on
each of the characteristics mentioned above. Chi-square
tests were used for categorical variables and t-tests for con-
tinuous variables. Consequently, logistic regression anal-
ysis was used to look for independent predictors of a
positive culture result, adjusted for differences in the other
characteristics. Continuous variables (such as age) were
first examined to check whether there was a linear relation
between the potential confounder and the outcome. Vari-
ables showing a non-linear relation with the outcome
were categorised. A p-value of less than 0.05 was consid-
ered statistically significant in all analyses.
Results
Of all admissions with reported SSI, 523 (74.6%) had a
positive culture result, 102 (14.6%) a negative culture
result and 76 (10.8%) were classified as unknown culture
result. Table 1 shows differences between SSI with known
and unknown culture results. SSI with unknown culture
results were less often diagnosed in males, less often high-
risk patients and more often concerned the less severe SSI
that do not require reoperation. In other words, given a
culture being taken, chances are higher that the SSI results
in more morbidity (e.g. reoperation).
Table 1: Characteristics of 701 patient admissions with reported surgical site infection, and differences between those with known and 
unknown culture results (Leiden University Medical Centre, 1997-2005)
Known
N = 625
Unknown
N = 76
Test of difference
% male patients 54.2% 38.2% X2 = 7.03 p < 0.01
Average age (SD) 57.1 (18.4) 60.4 (15.6) t = -1.67 p = 0.10
% ASA class > = 3 34.1% 15.8% X2 = 10.40 p < 0.01
Period
% in 2003-2005 43.7% 51.3% X2 = 1.60 p = 0.21
Type of patients
% (cardio)vascular 14.9% 17.1% X2 = 0.26 p = 0.61
% trauma 17.8% 26.3% X2 = 3.26 p = 0.07
% digestive or gastrointestinal tract 44.8% 36.8% X2 = 1.74 p = 0.19
% other 22.6% 19.7% X2 = 0.31 p = 0.58
% less severe SSI 70.6% 82.9% X2 = 5.10 p = 0.02BMC Infectious Diseases 2009, 9:176 http://www.biomedcentral.com/1471-2334/9/176
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We further examined these SSI with unknown culture
results to explore the reasons for not obtaining a culture.
Of the 76 reported SSI with unknown culture results, 18
(23.7%) were drained without a culture being taken, 24
(31.6%) only had redness of the skin and/or pain without
any other symptoms, 6 (7.9%) were presented with serous
fluid, redness, swelling and/or pain, and 3 (3.9%) had cel-
lulitis. Given that SSI were only reported if treated, the
question is whether antibiotic treatment was necessary in
these patients with only redness of the skin without other
symptoms. For all these patients with SSI, no culture was
taken. One (1.3%) had a culture taken during the week-
end, which was not processed for unknown reasons. For
10 (13.2%) the patient records provided no further infor-
mation. For 14 (18.4%) patients with unknown culture
results, the written patient records could not be obtained.
This was due to various reasons e.g. because they were in
circulation at the moment of inquiry. The latter group of
patients did not differ from the other patients with
unknown culture results on any of the characteristics in
table 1 (data not shown) so that it can be assumed that the
reasons for not taking a culture were also similar in these
patients. The SSI with unknown culture results were
excluded from further analyses, thereby leaving 625
patient admissions.
Culture results
Comparing SSI with positive and negative culture results,
positive culture results more often concerned SSI reported
in high-risk patients (table 2), which may represent the
higher risk of infections in this group of patients. How-
ever, it is also shown that positive culture results less often
concerned SSI reported in trauma patients and the less
severe SSI (table 2). The finding that positive culture
results less often concerned trauma patients was only
found for the period 2003-2005 (18.8% versus 44.0%, X2
= 14.41 p < 0.01) and not for the period before (14.3%
versus 7.7%, X2 = 1.69 p = 0.19). Furthermore, the finding
that positive culture results less often concerned the less
severe SSI was only found in trauma patients (49.4% ver-
sus 84.6%, X2 = 10.11 p < 0.01) and not in other patients
(72.6% versus 77.6%, X2 = 0.84 p = 0.36). This suggests
that the diagnosis of SSI in trauma patients may be
improved, in particular when suspecting a minor SSI, i.e.
by following a more conservative approach and not
administering antibiotics directly. These results did not
change when adjusted for differences in the other charac-
teristics: the probability of a positive culture result was
45% lower in trauma patients (Odds Ratio 0.55 [0.33-
0.94]), 44% lower in less severe SSI (Odds Ratio 0.56
[0.33-0.95]) and 77% higher in high-risk patients (Odds
Ratio 1.77 [1.07-2.95]).
Survey
A survey among surgeons was conducted when they were
unaware of the results mentioned above. The survey
showed that most surgeons agreed on the clinical symp-
toms based on which they would report a SSI: redness/
swelling was mentioned by 100%, pus by 65.2%, pain by
65.2% and fever by 60.9%. Of all surgeons, 73.9%
reported that they did not always take a wound swab
when a SSI was suspected, e.g. when only redness of the
skin was observed (34.8%) and/or when there was no
material to be collected (26.1%). Trauma surgeons on
average mentioned more criteria than other surgeons (3.0
vs 2.4), in particular fever which was mentioned by 75.0%
of the trauma surgeons vs. 57.9% of the other surgeons.
This may indicate that trauma surgeons use a lower
threshold or different criteria to diagnose a SSI, and may
initiate antibiotic treatment sooner than other surgeons.
Antibiotic treatment was reported to be initiated sooner in
the presence of osteosynthetic or prosthetic material
(69.6%), immunosuppressed patients (60.9%), heart
valve pathology (34.8%) and/or diabetes (21.7%). When
a SSI was suspected without additional sickness or risk fac-
tors, treatment consisted of drainage only. Trauma sur-
geons on average mentioned the same number of risk
Table 2: Characteristics of patient admissions with reported surgical site infection: differences between those with positive and 
negative culture results (Leiden University Medical Centre, 1997-2005)
Positive
N = 523
Negative
N = 102
Test of difference
% male patients 55.1% 50.0% X2 = 0.88 p = 0.35
Average age (SD) 57.0 (18.1) 57.7 (20.2) t = 0.35 p = 0.73
% ASA class > = 3 36.1% 23.5% X2 = 6.04 p = 0.01
Period
% in 2003-2005 42.6% 49.0% X2 = 1.41 p = 0.24
Type of patients
% (cardio)vascular 15.1% 13.7% X2 = 0.13 p = 0.72
% trauma 16.3% 25.5% X2 = 4.99 p = 0.03
% digestive or gastrointestinal tract 45.9% 39.2% X2 = 1.54 p = 0.22
% other 22.8% 21.6% X2 = 0.07 p = 0.79
% less severe SSI 68.8% 79.4% X2 = 4.60 p = 0.03BMC Infectious Diseases 2009, 9:176 http://www.biomedcentral.com/1471-2334/9/176
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factors for an earlier initiation of antibiotic treatment than
other surgeons (2.3 vs 2.4). When asked specifically about
antibiotic policy, three out of four trauma surgeons per-
ceived their antibiotic policy to have become very liberal
over time (against 1 out of 7 gastroenterologic/oncologic
surgeons). It was not possible to test whether prescription
behaviour had actually changed, since medication data
were only available in the hospital information system
from 2004 onwards. These survey results thus support the
interpretation of the data above that a more conservative
approach may be warranted in trauma patients.
Discussion
The present study has shown that the majority (75%) of
reported SSI had a positive culture result. These positive
culture results more often concerned patients that were
high-risk at admission, consistent with the general notion
of chances of infection in patients with diminished
health. However, positive culture results less often con-
cerned trauma patients and less severe SSI, thereby sug-
gesting that a more conservative approach with respect to
treatment of suspected SSI may be warranted in these
groups. In this way, routine reporting of SSI may help to
identify such groups, and thus give valuable feedback to
surgeons.
Our results seem to be similar to those from other studies.
Our annual reported SSI incidence varies between 2.3%
and 3.3% [8], within the range shown by other studies. In
the UK 168 hospitals participated in the Nosocomial
Infection National Surveillance Service (NINSS), showing
that 4% of all admissions were complicated by a SSI,
although the incidence varied considerably across hospi-
tals [17]. The CDC NNIS estimates an incidence of 2.6%
of SSI in the United States [16]. With respect to culture
results, our percentage of 75% was lower than described
by Giacometti et al. [18] where 91% of all 676 patients
who presented signs and symptoms indicative of SSI
showed pathological bacteria present. This gap of 16%
can be partially explained by the SSI with unknown cul-
tures in our study. These are likely to include some posi-
tive cultures had a culture been taken, as the presence of
clinical symptoms or the presence of pus in these patients
makes a SSI likely even if unconfirmed by culture results.
However, assuming that all of these unknown culture
results would have had positive culture results, the per-
centage would still only be 85%, suggesting that the initial
diagnosis of suspected SSI can be improved. This explana-
tion is supported by the fact that approximately one-third
of the patients with unknown culture results only had red-
ness of the skin and/or pain without any other symptoms.
Our survey showed that surgeons may initiate antibiotic
treatment sooner if prosthetic material is present in
patients. Unfortunately, we did not have complete infor-
mation for each patient whether prosthetic material was
present or not. If surgeons initiate antibiotic treatment
sooner - i.e. with only few symptoms - because of pros-
thetic material being present, culture results may more
often come back negative. This may explain why negative
culture results more often concerned trauma patients,
since prosthetic material is relatively common in these
patients. However, we would then expect to find similar
results in vascular patients, given the commonly present
vascular prostheses. Since this was not the case, it seems
unlikely for this to be the entire explanation.
Different groups of patients were distinguished to explore
which type of patients more often had unknown or nega-
tive culture results, thereby guiding decision making of
the different surgical wards. Infectious risk factors may be
different in these groups, which may bias the comparison
between these groups. Whereas a complicated fracture is a
risk factor for infection in trauma patients, comorbidity of
the patient and previous (groin) surgery are important
risk factors in vascular patients. Since such data were not
available for the present study, the comparison of culture
results between surgery groups should be interpreted as a
signal that decision making in trauma patients may be
improved, rather than as an explanatory factor. This inter-
pretation of the data is supported by our findings in the
survey where trauma surgeons themselves also perceived
their antibiotic policy to be very liberal.
The finding that positive culture results less often con-
cerned trauma patients was only found for the period
2003-2005 and not for earlier periods, suggesting that the
increase in reported SSI from 2002 onwards [8] is most
likely due to more SSI with negative culture results being
reported in trauma patients, in particular the less severe
SSI. This interpretation is consistent with our survey find-
ings where trauma surgeons perceived their antibiotic pol-
icy to have become very liberal over time. This perceived
change in antibiotic policy may have been (partly) due to
the arrival of a new head of the trauma surgeons, who sup-
ported this liberal antibiotic policy, thereby creating a
gradual cultural change towards increased prescription of
antibiotics.
In diagnosing a SSI the physician is left with his clinical
judgment as wound swabs take days to produce results, in
contrast to other infections (pneumonia, or urinary tract
infection) were either X-ray or a urinary sediment can
complement the diagnosis directly. This undoubtedly
leaves more subjectivity in diagnosing a SSI, which can be
sensitive to changes over time as a result of perceived risk
perception, staff composition and/or cultural changes
within a department. Quicker diagnostic methods would
prove to be a considerable advantage, but are currently
not yet available for hospital practice. Clearer guidelinesPublish with BioMed Central    and   every 
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on e.g. which and how many symptoms should be
present, may help physicians to diagnose a SSI. The Eng-
lish NINSS has already included this: two of the following
criteria (pain or tenderness, redness, heat and localized
swelling) need to be present to diagnose a SSI [19]. Such
a higher threshold may be particularly useful in some
patients as identified in the present study. The results of
the present study have increased the focus on the criteria
for diagnosis and treatment of SSI in our surgical depart-
ment, in particular in trauma patients and in less severe
SSI, e.g. in meetings discussing adverse outcomes and the
extent to which these should have been treated differently.
Routine reporting of SSI over time has thus helped to
improve diagnosis and treatment of SSI, by giving feed-
back to surgeons in which patients a more conservative
approach may be warranted, and in this way has
improved quality of care for future patients.
Conclusion
Routine reporting of SSI was mostly supported by culture
results. However, this support was less often found in
trauma patients and less severe SSI, thereby giving sur-
geons feedback that diagnosis and treatment may be
improved in these cases.
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